fbpx

Health Care

Merck

Merck to acquire VelosBio for $2.75B (access required)

“We are very pleased that Merck has recognized the value of our first-in-class ROR1-directed investigational therapeutics. As part of Merck’s oncology pipeline, our lead product candidate, VLS-101, is now well positioned to achieve its maximum potential to benefit appropriate cancer patients in need," said VelosBio founder and CEO Dave Johnson.

Read More »

A seat at the table

In the battle against the COVID-19 resurgence, quality care and safe working conditions in every health care facility should be a priority. By Debbie White, registered nurse and president of Health Professionals and Allied Employees.

Read More »

An ER on wheels (access required)

No one ever wants it to happen, a car crash or household accident that leaves a person’s life hanging in the balance. As the victims wait for emergency responders to arrive they can only hope the team that comes will be able to do enough to help until they get to a hospital where all their needs can be met. Fairfield-based nonprofit MD1 is setting out to change that by bringing the emergency room to the scene.

Read More »